首页> 中文期刊> 《世界核心医学期刊文摘:眼科学分册》 >眼压升高和青光眼及使用抗青光眼药物与5年伴发白内障的关系:蓝山眼科研究

眼压升高和青光眼及使用抗青光眼药物与5年伴发白内障的关系:蓝山眼科研究

         

摘要

Purpose: To examine incident relationships between elevated intraocular pressure (IOP), open-angle glaucoma (OAG), and use of glaucoma medications with 5- year incident cataract. Design: Population-based cohort study. Participants: The Australian Blue Mountains Eye Study examined 3654 participants 21 mmHg in either eye were classified as having ocular hypertension (OH), as were non-OAG subjects with IOP < 22 mmHg using glaucoma medications. Wisconsin levels 4 to 5 were graded as nuclear cataract, at least 5% lens involvement was graded as cortical cataract, and any PSC defined its presence. Results: The 5- year incidence of nuclear cataract was 23.4% (592/2532), or 23.1% (574/2486) after excluding subjects using glaucoma medication. A marginally significant association was found for elevated IOP or OH at baseline and incident nuclear cataract (odds ratio [OR] 1.93 95% confidence interval (CI), 0.97- 3.89, and OR, 1.83 95% CI, 0.96- 3.48, respectively) in subjects not using glaucoma medications, after multivariate adjustment. Age-and gender-adjusted analyses showed similar but statistically significant associations. The association between elevated IOP or OH and nuclear cataract was signifi-cant in multivariate analyses (OR, 2.07 95% CI, 1.04- 3.12, and OR, 1.78 95% CI, 1.05- 3.01 , respectively). Use of glaucoma medications was associated with nonsignificantly increased adjusted odds for incident nuclear cataract (OR, 1.90 95% CI, 0.92- 3.92). No associations, however, were found with incident cortical cataract or PSC. Conclusions: Elevated IOP may increase the risk of nuclear cataract, but not that of other types. The use of glaucoma medications could magnify this risk.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号